Gene Technology Act (GTA)
English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.
Art. 36 Amendment of current legislation
The amendment of current legislation is regulated in the Annex.
Art. 37 Transitional period for the use of antibiotic resistance genes
Resistance genes to antibiotics used in human and veterinary medicine may be used in field trials until 31 December 2008.
Art. 37a Transitional period for putting genetically modified organisms into circulation
1 No authorisations may be granted until 31 December 2021 for putting into circulation genetically modified plants and parts of plants, genetically modified seeds and other plant propagation material and genetically modified animals for agricultural, horticultural or silvicultural purposes. 2 The Federal Council shall submit draft legislation to the Federal Assembly by mid-2024 at the latest on a risk-based authorisation regime for plants, parts of plants, seeds and other plant propagation material for agricultural, horticultural or silvicultural purposes which have been cultivated using methods of new cultivation technologies, into which no transgenic genetic material has been inserted and which have a proven added value for agriculture, the environment or consumers compared with conventional cultivation methods.
Art. 37a — Inserted by No I of the FA of 19 March 2010 (AS 2010 3233; BBl 2009 5435). Amended by No I of the FA of 18 March 2022, in force since 1 Jan. 2022 (AS 2022 415; BBl 2021 1655).
Art. 38 Referendum and commencement
1 This Act is subject to optional referendum. 2 The Federal Council determines the commencement date. Commencement date: 1 January 2004 Annex No 4 Art. 54 para. 2 second sentence: 1 August 2005Annex No 3 Art. 7a, 7c and 29 No 1 let. abis and aquater: 2 May 2006the other articles in Annex No 3: at a later date
Para. 2 — FCD of 19 Nov. 2003. Para. 2 — AS 2005 2601, 2293 Para. 2 — AS 2006 1425